Autoimmune diseases as the loss of active "self-control"

被引:35
作者
Bach, JF [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U580, F-75015 Paris, France
来源
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION | 2003年 / 998卷
关键词
immunoregulation; CD25+T cells; NKT cells; autoimmune diseases;
D O I
10.1196/annals.1254.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Converging experimental evidence indicates that the clinical expression of autoimmunity is under the control of T cell-mediated immunoregulatory circuits. Several types of suppressor T cells have been described. Some of them are closely dependent upon cytokines such as TH2 cells and Tr1 cells. Others appear to rely more on cell-cell contact (such as CD25+ CD62L+ T cells), although some cytokines, notably TGF-beta, may be involved in their growth or their mode of action. It is tempting to separate suppressor cells that appear spontaneously, such as CD25+ T cells and NKT cells (innate immunoregulation), from those that are only observed after antigen administration, such as TH2 cells and Tr1 cells (adaptive immunoregulation). The role of these diverse cell types in the control of the onset or the progression of autoimmune diseases is likely, but still a matter of debate. A central question is to determine whether immune dysregulation precedes the burst of pathogenic autoimmunity.
引用
收藏
页码:161 / 177
页数:17
相关论文
共 120 条
  • [41] Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
    Herold, KC
    Hagopian, W
    Auger, JA
    Poumian-Ruiz, E
    Taylor, L
    Donaldson, D
    Gitelman, SE
    Harlan, DM
    Xu, DL
    Zivin, RA
    Bluestone, JA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (22) : 1692 - 1698
  • [42] Animal models of inflammatory bowel disease
    Hibi, T
    Ogata, H
    Sakuraba, A
    [J]. JOURNAL OF GASTROENTEROLOGY, 2002, 37 (06) : 409 - 417
  • [43] HIGGINS PJ, 1988, J IMMUNOL, V140, P440
  • [44] The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
    Hong, S
    Wilson, MT
    Serizawa, I
    Wu, L
    Singh, N
    Naidenko, OV
    Miura, T
    Haba, T
    Scherer, DC
    Wei, J
    Kronenberg, M
    Koezuka, Y
    Van Kaer, L
    [J]. NATURE MEDICINE, 2001, 7 (09) : 1052 - 1056
  • [45] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061
  • [46] Horsfall AC, 1997, J IMMUNOL, V159, P5687
  • [47] In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis
    Inobe, J
    Chen, YH
    Weiner, HL
    [J]. ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 : 390 - 392
  • [48] IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies
    Johansson, ÅCM
    Hansson, AS
    Nandakumar, KS
    Bäcklund, J
    Holmdahl, R
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (06) : 3505 - 3512
  • [49] Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
    Joosten, Leo A. B.
    Lubberts, Erik
    Helsen, Monique M. A.
    Saxne, Tore
    Coenen-de Roo, Christina J. J.
    Heinegard, Dick
    van den Berg, Wim B.
    [J]. ARTHRITIS RESEARCH, 1999, 1 (01) : 81 - 91
  • [50] Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial
    Kalliomäki, M
    Salminen, S
    Arvilommi, H
    Kero, P
    Koskinen, P
    Isolauri, E
    [J]. LANCET, 2001, 357 (9262) : 1076 - 1079